121 related articles for article (PubMed ID: 9203637)
1. Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins.
Burstein ES; Spalding TA; Brann MR
Mol Pharmacol; 1997 Feb; 51(2):312-9. PubMed ID: 9203637
[TBL] [Abstract][Full Text] [Related]
2. Functional partial agonism at cloned human muscarinic acetylcholine receptors.
Bräuner-Osborne H; Ebert B; Brann MR; Falch E; Krogsgaard-Larsen P
Eur J Pharmacol; 1996 Oct; 313(1-2):145-50. PubMed ID: 8905341
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of the m5 muscarinic receptor by a series of mutations at the extracellular end of transmembrane 6.
Spalding TA; Burstein ES; Wells JW; Brann MR
Biochemistry; 1997 Aug; 36(33):10109-16. PubMed ID: 9254607
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of muscarinic receptors by the G-protein Gq.
Burstein ES; Spalding TA; Braüner-Osborne H; Brann MR
FEBS Lett; 1995 Apr; 363(3):261-3. PubMed ID: 7737412
[TBL] [Abstract][Full Text] [Related]
5. Interactions of muscarinic receptors with the heterotrimeric G proteins Gq and G12: transduction of proliferative signals.
Burstein ES; Bräuner-Osborne H; Spalding TA; Conklin BR; Brann MR
J Neurochem; 1997 Feb; 68(2):525-33. PubMed ID: 9003037
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis.
Spalding TA; Burstein ES; Brauner-Osborne H; Hill-Eubanks D; Brann MR
J Pharmacol Exp Ther; 1995 Dec; 275(3):1274-9. PubMed ID: 8531092
[TBL] [Abstract][Full Text] [Related]
7. Characterization of M2 muscarinic receptor activation of different G protein subtypes.
Uustare A; Näsman J; Akerman KE; Rinken A
Neurochem Int; 2004 Jan; 44(2):119-24. PubMed ID: 12971914
[TBL] [Abstract][Full Text] [Related]
8. M1, M3 and M5 muscarinic receptors stimulate mitogen-activated protein kinase.
Wotta DR; Wattenberg EV; Langason RB; el-Fakahany EE
Pharmacology; 1998 Apr; 56(4):175-86. PubMed ID: 9566019
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.
Stevens LA; Sellers DJ; McKay NG; Chapple CR; Chess-Williams R
Auton Autacoid Pharmacol; 2006 Jul; 26(3):303-9. PubMed ID: 16879496
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor subtypes controlling the cationic current in guinea-pig ileal smooth muscle.
Zholos AV; Bolton TB
Br J Pharmacol; 1997 Nov; 122(5):885-93. PubMed ID: 9384504
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells.
Watson N; Daniels DV; Ford AP; Eglen RM; Hegde SS
Br J Pharmacol; 1999 May; 127(2):590-6. PubMed ID: 10385263
[TBL] [Abstract][Full Text] [Related]
12. Human muscarinic receptors expressed in A9L and CHO cells: activation by full and partial agonists.
Richards MH; van Giersbergen PL
Br J Pharmacol; 1995 Mar; 114(6):1241-9. PubMed ID: 7620715
[TBL] [Abstract][Full Text] [Related]
13. Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder.
Schneider T; Hein P; Michel-Reher MB; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):71-8. PubMed ID: 16059734
[TBL] [Abstract][Full Text] [Related]
14. Constitutive inhibitory action of muscarinic receptors on adenylyl cyclase in cardiac membranes and its stereospecific suppression by hyoscyamine.
Rícný J; Gualtieri F; Tucek S
Physiol Res; 2002; 51(2):131-7. PubMed ID: 12108922
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): high throughput assays in mammalian cells.
Bräuner-Osborne H; Brann MR
Eur J Pharmacol; 1996 Jan; 295(1):93-102. PubMed ID: 8925880
[TBL] [Abstract][Full Text] [Related]
17. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry.
Wood MD; Murkitt KL; Ho M; Watson JM; Brown F; Hunter AJ; Middlemiss DN
Br J Pharmacol; 1999 Apr; 126(7):1620-4. PubMed ID: 10323594
[TBL] [Abstract][Full Text] [Related]
18. Myopia-Inhibiting Concentrations of Muscarinic Receptor Antagonists Block Activation of Alpha2A-Adrenoceptors In Vitro.
Carr BJ; Mihara K; Ramachandran R; Saifeddine M; Nathanson NM; Stell WK; Hollenberg MD
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2778-2791. PubMed ID: 29860464
[TBL] [Abstract][Full Text] [Related]
19. Identification of a ligand-dependent switch within a muscarinic receptor.
Spalding TA; Burstein ES; Henderson SC; Ducote KR; Brann MR
J Biol Chem; 1998 Aug; 273(34):21563-8. PubMed ID: 9705286
[TBL] [Abstract][Full Text] [Related]
20. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
Forray C; el-Fakahany EE
Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
